Condition
Posterior Reversible Encephalopathy Syndrome
Total Trials
7
Recruiting
1
Active
1
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
Trial Status
Completed4
Unknown2
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04950270CompletedPrimary
Copeptin Kinetics in Critically Ill Patients With Posterior Reversible Encephalopathy Syndrome
NCT02665598UnknownPrimary
Prognostic Observation of Posterior Reversible Encephalopathy Syndrome
NCT05433870CompletedPrimary
Inflammatory Biomarkers for the Diagnosis of oPRES
NCT05310513CompletedPrimary
The Predictors of ICU Admission of oPRES
NCT05143710CompletedPrimary
The Clinical and Prognostic Features of PRES
NCT05140850Unknown
Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES
NCT03470467RecruitingPrimary
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
Showing all 7 trials